×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
山东大学 [10]
中国医学科学院 北京... [6]
复旦大学上海医学院 [5]
西安交通大学 [4]
中南大学 [3]
武汉大学 [3]
更多...
内容类型
期刊论文 [41]
会议论文 [1]
发表日期
2019 [10]
2018 [15]
2017 [5]
2016 [4]
2015 [6]
2012 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共42条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 卷号: 7
作者:
Yang, Dong
;
Su, Bin
;
Dai, Hongjiu
;
Li, Wenxuan
;
Shi, Lan
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2019/12/04
Chimeric antigen receptor
Glioblastoma
Cancer stem cell
NKG2D
CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 卷号: 68, 期号: 3
作者:
Zi, Zhenguo
;
Jin, Yanling
;
Li, Gaoxin
;
Shao, Kang
;
Cai, Qiliang
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2019/12/05
Mesothelin
Chimeric antigen receptor
Programmed cell death protein 1
SgRNA-guided clustered regularly interspaced short palindrome repeats-associated nuclease Cas9
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen
期刊论文
FRONTIERS IN IMMUNOLOGY, 2019, 卷号: 10
作者:
Timmers, Marijke
;
Roex, Gils
;
Wang, Yuedi
;
Campillo-Davo, Diana
;
Van Tendeloo, Viggo F., I
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2019/12/05
chimeric antigen receptor-modified T cells
immunotherapy
multiple myeloma
B cell maturation antigen
CD19
CD138
CD38
SLAMF7/CS1
Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma.
期刊论文
Annals of hematology, 2019, 卷号: 98, 页码: 813-822
作者:
Ma Tiantian
;
Shi Jing
;
Liu Huasheng
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/11/19
Chimeric antigen receptor T cell
BCMA
B cell maturation antigen
CAR-T
Multiple myeloma
MM
Targeted immunotherapy
Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer
期刊论文
FRONTIERS IN ONCOLOGY, 2019, 卷号: 9
作者:
Shang, Yufeng
;
Zhou, Fuling
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/12/05
immunotherapy
acute myeloid leukemia
acute lymphoblastic leukemia
antibody-drug conjugate
bispecific antibody
chimeric antigen receptor
immune checkpoint
Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients.
期刊论文
International journal of cancer, 2019
作者:
Sophia Stock
;
Rudolf Übelhart
;
Maria-Luisa Schubert
;
Fuli Fan
;
Bailin He
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2019/12/13
Phosphatidylinositol
3-kinase
(PI3K)
chimeric
antigen
receptor
(CAR)
chronic
lymphocytic
leukemia
idelalisib
immunotherapy
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
期刊论文
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, 期号: 150
作者:
Davidson, Howard W.
;
Cepeda, Joseph Ray
;
Sekhar, Nitin S.
;
Hang, Junying
;
Gao, Ling
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/11
Immunology and Infection
Issue 150
Type 1 Diabetes
antigen
specificity
monoclonal antibody
chimeric antigen receptor
transduction
insulin
epitope
CD8 T cell
NOD mouse
Natural Killer Cell-Based Immunotherapy for Cancer: Advances and Prospects
期刊论文
ENGINEERING, 2019, 卷号: 5, 期号: 1, 页码: 106-114
作者:
Hu, Yuan
;
Tian, Zhigang
;
Zhang, Cai
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/11
Natural killer cell
Immunotherapy
Cancer
Clinical trial
Chimeric
antigen receptor
Induced CD20 Expression on B-Cell Malignant Cells Heightened the Cytotoxic Activity of Chimeric Antigen Receptor Engineered T Cells
期刊论文
2019, 卷号: 30, 期号: 4,SI, 页码: 497-510
作者:
Xu, Yingxi
;
Li, Saisai
;
Wang, Ying
;
Liu, Jia
;
Mao, Xinhe
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2020/01/03
chimeric antigen receptor
CD20
Immunotherapy
B-cell malignancies
HDAC inhibitor
EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC
期刊论文
Aging-Us, 2019, 卷号: 11, 期号: 23, 页码: 11054-11072
作者:
Y.Liu
;
Y.H.Zhou
;
K.H.Huang
;
Y.Li
;
X.J.Fang
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/08/24
triple-negative breast cancer,human epidermal growth factor receptor,chimeric antigen receptor engineered T cells,negative breast-cancer,growth-factor receptor,therapy,amplification,inhibition,expression,challenges,mutations,her2,Cell Biology,Geriatrics & Gerontology
©版权所有 ©2017 CSpace - Powered by
CSpace